Intérêt de quelques marqueurs tumoraux = Value of some tumoral markersHUMBLET, Y.Louvain médical. 2002, Vol 121, Num 7, pp 328-331, issn 0024-6956Article

Les urgences en oncologie au niveau du médecin traitant = Oncologic emergencies and the general practicionerHUMBLET, Y.Louvain médical. 2000, Vol 119, Num 1, pp S6-S13, issn 0024-6956Article

LA GREFFE DE MOELLE OSSEUSE HUMAINE ALLOGENIQUE.SYMANN M; RUDHAIN J; HUMBLET Y et al.1977; LOUVAIN MED.; BELG.; DA. 1977; VOL. 96; NO 3; PP. 115-120; ABS. ANGL.; BIBL. 6 REF.Article

BEE STINGS AND ACUTE TUBULAR NECROSISHUMBLET Y; SONNET J; VANYPERSELE DE STRIHOU C et al.1982; NEPHRON; ISSN 0028-2766; CHE; DA. 1982; VOL. 31; NO 2; PP. 187-188; BIBL. 5 REF.Article

Small cell lung cancer : high-dose late intensification chemotherapy with autologous bone marrow transplantationHUMBLET, Y; SYMANN, M.Bone marrow transplantation. Supplement (Basingstoke). 1992, Vol 10, Num 2, issn 0951-3078, p. 33Conference Paper

LES CANCERS: HASARD OU DESTIN: GUÉRISON OU CHRONICITÉ ? : 20 ans d'amitié ECU-UCL/AlformecHUMBLET, Y; LAMBERT, M.Louvain médical. 2009, Vol 128, Num 5, pp 209-212, issn 0024-6956, 4 p.Conference Paper

Néphrotoxicité du cisplatine : Quelle prévention en pratique ? = Cisplatin nephrotoxicity : Which prevention, practically ?VERSCHAEVE, V; HUMBLET, Y; JADOUL, M et al.Louvain médical. 1997, Vol 116, Num 2, pp 55-62, issn 0024-6956Article

Diagnosis of pulmonary embolism with 16-slice CTSALOVIC, D; HUMBLET, Y; COCHE, E et al.Journal belge de radiologie (1924). 2003, Vol 86, Num 2, issn 0302-7430, p. 113Article

Accident vasculaire cérébral chez un patient cancéreux : Penser à l'endocardite thrombotique non bactérienne (Endocardite Marastique) à propos d'un casMARCHANDISE, S; HUMBLET, Y; LAMBERT, M et al.Louvain médical. 2007, Vol 126, Num 6, pp 175-178, issn 0024-6956, 4 p.Article

Textiloma on PET-CTCOCHE, E; HUMBLET, Y; LONNEUX, M et al.JBR-BTR (Bruxelles). 2008, Vol 91, Num 4, pp 180-180, issn 1780-2393, 1 p.Article

IN VIVO STUDIES OF A MURINE MYELOBLASTIC LEUKEMIASYMANN M; RODHAIN J; HUYBRECHTS M et al.1980; NOUV. REV. FR. HEMATOL.; FRA; DA. 1980; VOL. 22; NO 1; PP. 63-68; BIBL. 15 REF.Article

Les cancers bronchiques : Aspects thérapeutiques = Lung cancer : Therapeutic aspectsWEYNANTS, P; HUMBLET, Y.Louvain médical. 1997, Vol 116, Num 5, pp S197-S208, issn 0024-6956Article

La résistance à la chimiothérapie: progrès récents = Drug resistance in cancer chemotherapyANDRE, M; MICHEL, F; THYS, F et al.Acta Clinica Belgica. 1994, Vol 49, Num 5, pp 214-219, issn 0001-5512Article

Resistance to cisplatin : how to deal with the problem ?CANON, J.-L; HUMBLET, Y; SYMANN, M et al.European journal of cancer & clinical oncology. 1990, Vol 26, Num 1, pp 1-3, issn 0277-5379Article

Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancerMACHIELS, J.-P; SEMPOUX, C; LAURENT, S et al.Annals of oncology. 2007, Vol 18, Num 4, pp 738-744, issn 0923-7534, 7 p.Article

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanomaKIVELÄ, T; SUCIU, S; HUMBLET, Y et al.European journal of cancer (1990). 2003, Vol 39, Num 8, pp 1115-1120, issn 0959-8049, 6 p.Article

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical reportMARCHAND, M; PUNT, C. J. A; AVRIL, M.-F et al.European journal of cancer (1990). 2003, Vol 39, Num 1, pp 70-77, issn 0959-8049, 8 p.Article

Meropenem versus ceftazidime as empirical monotherapy for febrile neutropenic cancer patientsVANDERCAM, B; GERAIN, J; HUMBLET, Y et al.Annals of hematology (Print). 2000, Vol 79, Num 3, pp 152-157, issn 0939-5555Article

Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited-disease small-cell lung cancer : Prolonged intrathoracic tumor control and high central nervous system relapse rateVAN DE VELDE, H; BOSQUEE, L; WEYNANTS, P et al.Annals of oncology. 1999, Vol 10, Num 9, pp 1051-1057, issn 0923-7534Article

Primary squamous-cell carcinoma of the colonVRAUX, H; KARTHEUSER, A; HAOT, J et al.Acta chirurgica Belgica. 1994, Num 6, pp 318-320, issn 0001-5458Article

Immunological removal of cancer cells in bone marrow autografts: setting the experimental conditionsLEBACQ-VERHEYDEN, A.-M; HUMBLET, Y; RAVOET, A.-M et al.Monograph series of the European Organization for Research on Treatment of Cancer. 1984, Vol 14, pp 19-28, issn 0146-0447Article

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancerZAMAN, K; DURANDO, X; BAURAIN, J.-F et al.Breast cancer research and treatment. 2011, Vol 127, Num 3, pp 689-696, issn 0167-6806, 8 p.Article

Association of progression-free survival with patient-reported outcomes and survival : results from a randomised phase 3 trial of panitumumabSIENA, S; PEETERS, M; WOLF, M et al.British journal of cancer. 2007, Vol 97, Num 11, pp 1469-1474, issn 0007-0920, 6 p.Article

BRONCHOBILIARY FISTULA AND CHOLANGIOCARCINOMA : A CASE REPORT AND PRINCIPLES OF MANAGEMENTDELANDE, S; GOFFETTE, P; VERBAANDERT, C et al.Acta Clinica Belgica. 2007, Vol 62, Num 6, pp 438-441, issn 0001-5512, 4 p.Article

Compassionate use of Gemzar in advanced pancreatic cancer: a Belgian experienceHUMBLET, Y; VAN CUTSEM, E; DUBOIS, C et al.Acta gastro-enterologica belgica (English ed.). 2001, Vol 64, Num 4, pp 305-308, issn 1784-3227Article